Navigation Links
Heroin and Hepatitis C – A Dangerous Partnership
Date:1/8/2013

Los Angeles, CA (PRWEB) January 08, 2013

Heroin is the most common name for an illegal and often more potent form of morphine, a drug used to provide comfort in times of great pain. While forms of morphine can be extremely beneficial to those in need, heroin is extremely addictive and prolonged use often leads to immune suppression and various deadly infections. The hepatitis C virus is an infectious disease affecting primarily the liver for which there is no preventative vaccine, and often leads to cirrhosis and even liver failure. According to the World Health Organization it is estimated that between 130 to 170 million people worldwide are living with the virus. Through their patient admittance records Sovereign Health of California has noticed a dramatic increase in heroin addiction at their drug rehab center. Using their newly created technology enhanced after care monitoring program (T.E.A.M.) Sovereign Health hopes to ensure long term sobriety from opiates and a decrease in the spread of hepatitis C.

Individually these two public health risks affect millions of people worldwide and cost millions of dollars in public health expenses as well. However, researchers are now finding an even more dangerous link between the two risks. In a 2011 study published recently by the Centers for Disease Control and the Wisconsin Division of Public Health, researchers found that the primary cause of hepatitis C infection in Wisconsin was people sharing needles to inject heroin. Since heroin is commonly injected, users often share needles, and therefore infectious diseases with each other, leading to this deadly combination of health risks.

As a combination, heroin use and hepatitis C pose an even greater threat. Since heroin is so commonly injected, hepatitis can spread rapidly among hero
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Philadelphia Malpractice Lawyers at Console & Hollawell Explore Negligence as Overdoses from Prescription Painkillers Now Kill More People than Heroin
2. NIDA supports development of combined anti-heroin and HIV vaccine
3. Abuse-Resistant Oxycontin May Be Driving Addicts to Heroin
4. Heroin Addicts Have Higher Pain Sensitivity, Even During Treatment
5. New Pills Show Promise for Hepatitis C
6. Wake-Up Call: Medical Malpractice Attorneys at Console & Hollawell Express Concern After Surgeon Gives Hepatitis B to Patients
7. Trying to halt hepatitis Cs molecular hijacking
8. Patient Survival Rises When Drugs Suppress Hepatitis C in Blood: Study
9. Hepatitis: The Hidden Hazard
10. One Mans Harrowing Battle With Hepatitis C
11. Boomers With Hepatitis C Boosting Demand for Liver Transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: